Celerion deploys VCT fingerprint technology at clinical trial facilities
Clinical research solutions provider Celerion has deployed the Verified Clinical Trials (VCT) biometric fingerprint technology to prevent dual enrolment in clinical trials.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Clinical Trials | Pharmaceuticals